4-Phenyl butyric acid does not generally reduce glucose levels in rodent models of diabetes

Clinical and Experimental Pharmacology and Physiology

Volumn 37, Issue 4, 2010, Pages 441-446

  Xu, Tian Ying ^a   Chen, Ruo Hua ^a   Wang, Pei ^a   Zhang, Ruo Yu ^a   Ke, Sen Fang ^a   Miao, Chao Yu ^a  

^a SECOND MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

4 phenyl butyric acid; Endoplasmic reticulum stress; Glucose level; Type 1 diabetes; Type 2 diabetes

Indexed keywords

4 PHENYLBUTYRIC ACID; HYDROCORTISONE;

ALLOXAN DIABETES MELLITUS; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; C57BL 6 MOUSE; CONTROLLED STUDY; ENDOPLASMIC RETICULUM STRESS; GLUCOSE BLOOD LEVEL; GOTO KAKIZAKI RAT; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN RESISTANCE; MALE; MOUSE; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; RAT; STRAIN DIFFERENCE; WISTAR KYOTO RAT;

ANIMALS; BLOOD GLUCOSE; BLOOD PROTEINS; DIABETES MELLITUS, EXPERIMENTAL; DIABETES MELLITUS, TYPE 1; DIABETES MELLITUS, TYPE 2; DISEASE MODELS, ANIMAL; GLYCOPROTEINS; GLYCOSYLATION; HOMEOSTASIS; HYPERGLYCEMIA; HYPOGLYCEMIC AGENTS; INSULIN; INSULIN RESISTANCE; MALE; MICE; MICE, INBRED C57BL; MICE, OBESE; OBESITY; PHENYLBUTYRATES; RATS; RATS, INBRED WKY; SPECIES SPECIFICITY; TIME FACTORS;

EID: 77949902607     PISSN: 03051870     EISSN: 14401681     Source Type: Journal    
DOI: 10.1111/j.1440-1681.2009.05328.x     Document Type: Article

References (24)

1. Nakatani Y, Kaneto H, Kawamori D et al. Involvement of endoplasmic reticulum stress in insulin resistance and diabetes. J. Biol. Chem. 2005 280 : 847 851.
2. Kaneto H, Nakatani Y, Kawamori D et al. Role of oxidative stress, endoplasmic reticulum stress, and c-Jun N-terminal kinase in pancreatic beta-cell dysfunction and insulin resistance. Int. J. Biochem. Cell Biol. 2005 37 : 1595 1608.
3. Ozcan L, Ergin AS, Lu A et al. Endoplasmic reticulum stress plays a central role in development of leptin resistance. Cell Metab. 2009 9 : 35 51.
4. Sundar Rajan S, Srinivasan V, Balasubramanyam M, Tatu U. Endoplasmic reticulum (ER) stress & diabetes. Indian J. Med. Res. 2007 125 : 411 424.
5. Ozcan U, Yilmaz E, Ozcan L et al. Chemical chaperones reduce ER stress and restore glucose homeostasis in a mouse model of type 2 diabetes. Science 2006 313 : 1137 1140.
6. Marx J. Cell biology. A stressful situation. Science 2006 313 : 1564 1566.
7. Zeng J, Zhang Y, Mo J, Su Z, Huang R. Two-kidney, two clip renovascular hypertensive rats can be used as stroke-prone rats. Stroke 1998 29 : 1708 1713.
8. Huang F, Wu W. Antidiabetic effect of a new peptide from Squalus mitsukurii liver (S-8300) in alloxan-diabetes. Clin. Exp. Pharmacol. Physiol. 2005 32 : 521 525.
9. Severino C, Brizzi P, Solinas A, Secchi G, Maioli M, Tonolo G. Low-dose dexamethasone in the rat: A model to study insulin resistance. Am. J. Physiol. Endocrinol. Metab. 2002 283 : E367 73.
10. Cao L, Gu ZL, Mao CP. Effect of puerarin in insulin resistance in diabetic mice. Chinese Tradit. Herbal Drugs 2006 37 : 901 904.
11. Gao X, Li B, Jiang H, Liu F, Xu D, Liu Z. Dioscorea opposita reverses dexamethasone induced insulin resistance. Fitoterapia 2007 78 : 12 15.
12. Wang P, Xu TY, Guan YF, Su DF, Fan GR, Miao CY. Perivascular adipose tissue-derived visfatin is a vascular smooth muscle cell growth factor: Role of nicotinamide mononucleotide. Cardiovasc. Res. 2009 81 : 370 380.
13. Sanchez RA, Masnatta LD, Pesiney C, Fischer P, Ramirez AJ. Telmisartan improves insulin resistance in high renin nonmodulating salt-sensitive hypertensives. J. Hypertens. 2008 26 : 2393 2398.
14. Chen YH, Pan BY, Geng BQ, Yong DG. Pharmacokinetics of a new anti-tumor drug sodium phenylbutyrate in rats in vivo. J. Pract. Oncol. 2003 18 : 134 136.
15. Gilbert J, Baker SD, Bowling MK et al. A phase I dose escalation and bioavailability study of oral sodium phenylbutyrate in patients with refractory solid tumor malignancies. Clin. Cancer Res. 2001 7 : 2292 2300.
16. Wang M, Wang P, Peng JL et al. The altered expression of glucose-regulated proteins 78 in different phase of streptozotocin-affected pancreatic beta-cells. Cell Stress Chaperones 2009 14 : 43 8.
17. Liu G, Sun Y, Li Z et al. Apoptosis induced by endoplasmic reticulum stress involved in diabetic kidney disease. Biochem. Biophys. Res. Commun. 2008 370 : 651 656.
18. Akerfeldt MC, Howes J, Chan JY et al. Cytokine-induced beta-cell death is independent of endoplasmic reticulum stress signaling. Diabetes 2008 57 : 3034 3044.
19. Wang XH, Qian RZ, Zhang W, Chen SF, Jin HM, Hu RM. MicroRNA-320 expression in myocardial microvascular endothelial cells and its relationship with insulin-like growth factor-1 in Type 2 diabetic rats. Clin. Exp. Pharmacol. Physiol. 2009 36 : 181 188.
20. Ozcan U, Cao Q, Yilmaz E et al. Endoplasmic reticulum stress links obesity, insulin action, and Type 2 diabetes. Science 2004 306 : 457 461.
21. Eizirik DL, Cardozo AK, Cnop M. The role for endoplasmic reticulum stress in diabetes mellitus. Endocr. Rev. 2008 29 : 42 61.
22. Movassat J, Bailbe D, Lubrano-Berthelier C et al. Follow-up of GK rats during prediabetes highlights increased insulin action and fat deposition despite low insulin secretion. Am. J. Physiol. Endocrinol. Metab. 2008 294 : E168 75.
23. Buren J, Lai YC, Lundgren M, Eriksson JW, Jensen J. Insulin action and signalling in fat and muscle from dexamethasone-treated rats. Arch. Biochem. Biophys. 2008 474 : 91 101.
24. Cnop M, Welsh N, Jonas JC, Jorns A, Lenzen S, Eizirik DL. Mechanisms of pancreatic beta-cell death in type 1 and type 2 diabetes: many differences, few similarities. Diabetes 2005 54 (Suppl. 2 S97 107.